The Oncology Institute, Inc. (TOI)

0,6198 -0,0192 (-3,00%) In data: 01:01PM EDT. Mercato aperto.

The Oncology Institute, Inc.

18000 Studebaker Road
Suite 800
Cerritos, CA 90703
United States
(562) 735-3226
https://theoncologyinstitute.com

Settore/i: Healthcare
Settore: Medical Care Facilities
Impiegati a tempo pieno: 800

Figure dirigenziali chiave

Nome	Titolo	Retribuzione	Esercitate	Anno di nascita
Mr. Richard Alan Barasch	Chairman of the Board	N/D	N/D	1954
Dr. Daniel Virnich FACHE, M.D., MBA	Chief Executive Officer	614,62k	N/D	1979
Mr. Mihir Arunkumar Shah CPA	Chief Financial Officer	505,13k	N/D	1978
Dr. Yale D. Podnos F.A.C.S., M.D., M.P.H.	Chief Medical Officer	535,36k	N/D	1972
Mr. Jeremy N. Castle M.B.A.	Chief Operations Officer	N/D	N/D	1984
Mr. Mark Hueppelsheuser Esq.	General Counsel	N/D	N/D	N/D
Mr. Jordan McInerney	Chief Development Officer	N/D	N/D	N/D

Gli importi risalgono al giorno 31 dicembre 2023 e i valori di compensazione riguardano l'anno fiscale che si chiude a tale data. La retribuzione include salari, bonus ecc. "Esercitate" è il valore delle opzioni esercitate durante l'anno fiscale. Valuta in USD.

Descrizione

The Oncology Institute, Inc., an oncology company, provides various medical oncology services in the United States. The company operates through three segments: Dispensary, Patient Services, and Clinical Trials & Other. It offers physician services, in-house infusion and dispensary, clinical trial, radiation, outpatient blood product transfusion, and patient support services, as well as educational seminars, support groups, and counseling services. The company also provides managing clinical trials, palliative care programs, stem cell transplants services, and other care delivery models associated with non-community-based academic and tertiary care settings; and conducts clinical trials for a range of pharmaceutical and medical device companies. It serves adult and senior cancer patients. The company has a strategic collaboration with Healthly Forge to offer cancer care services to patients in Southern California. The Oncology Institute, Inc. was founded in 2007 and is headquartered in Cerritos, California.

Governance aziendale

L'ISS Governance QualityScore di The Oncology Institute, Inc. al 1 maggio 2024 è 10. I criteri di valutazione fondamentali sono revisione: 10; Consiglio di Amministrazione: 10; diritti degli azionisti: 6; retribuzione: 10.

Punteggi di corporate governance forniti da Institutional Shareholder Services (ISS). I punteggi indicano il rango decile relativo all’indice o alla regione. Un punteggio di decile pari a 1 indica un governance risk più basso, mentre un punteggio di 10 indica un governance risk più alto.